Literature DB >> 474707

Degenerative vascular disease and myocardial infarction in mice with lupus-like syndrome.

L Accinni, F J Dixon.   

Abstract

The pathogenesis of the degenerative vascular disease and myocardial infarction that develop in mice with lupus-like disease was studied by immunofluorescence, light microscopy, and electron microscopy. Medium and small coronary arteries and arterioles of both infarcted and noninfarcted hearts had focal degenerative lesions consisting of deposits of periodic-acid--Schiff (PAS)-positive or eosinophilic material in the intima and to a lesser extent in the media, degenerative changes in the media without accompanying cellular inflammation, and occasional proliferation or swelling of intimal cells. These lesions often narrowed and, together with platelet aggregation, occasionally occluded the vascular lumens. Granular deposits of mouse immunoglobulin, C3, and occasionally gp70 were present in the walls of medium and small arteries, arterioles, and venules of both infarcted and noninfarcted myocardium. Dense deposits of foreign material were found by electron microscopy in areas corresponding to the immune deposits. These findings are consistent with the interpretation that these noninflammatory vascular lesions are caused by local deposition of antigen--antibody complexes. The immune-complex--mediated injury appears to lead to thrombotic and/or obliterative vascular changes that contribute to decrease of the coronary blood flow and to the development of myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 474707      PMCID: PMC2042457     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  CARDIAC LESIONS IN EXPERIMENTAL HYPERTENSION.

Authors:  R D MOORE; M D SCHOENBERG; S KOLETSKY
Journal:  Arch Pathol       Date:  1963-01

2.  FINE STRUCTURAL CHANGES IN MYOCARDIAL ISCHEMIC INJURY.

Authors:  R B JENNINGS; J H BAUM; P B HERDSON
Journal:  Arch Pathol       Date:  1965-02

3.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

4.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

5.  Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus.

Authors:  J Meller; C A Conde; L M Deppisch; E Donoso; S Dack
Journal:  Am J Cardiol       Date:  1975-02       Impact factor: 2.778

6.  Spherical microparticles in human myocardium: an ultrastructural study.

Authors:  V J Ferrans; K U Thiedemann; B J Maron; M Jones; W C Roberts
Journal:  Lab Invest       Date:  1976-10       Impact factor: 5.662

7.  Pathogenesis of the glomerulonephritis of NZB/W mice.

Authors:  P H Lambert; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

8.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

9.  Staining of tissue sections for electron microscopy with heavy metals.

Authors:  M L WATSON
Journal:  J Biophys Biochem Cytol       Date:  1958-07-25

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  19 in total

1.  Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.

Authors:  M Nose; M Nishimura; M Kyogoku
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

3.  The pathogenesis of murine systemic lupus erythematosus. Rous--Whipple Award lecture.

Authors:  F J Dixon
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

4.  Enzyme-linked immunosorbent assay for detection of retroviral gp70 and gp70-anti-gp70 immune complexes in sera from SLE mice.

Authors:  S Izui; G Lange
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

5.  Transfer of renovascular hypertension and coronary heart disease by lymphoid cells from SLE-prone mice.

Authors:  L Hang; P M Stephen-Larson; J P Henry; F J Dixon
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

Review 6.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

7.  Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction.

Authors:  F N Rowland; M J Donovan; P T Picciano; G D Wilner; D L Kreutzer
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

8.  Influence of diet on vascular lesions in autoimmune-prone B/W mice.

Authors:  G Fernandes; D R Alonso; T Tanaka; H T Thaler; E J Yunis; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

9.  Quantitative analysis of myocardial infarction in (NZW x BXSB)F1 hybrid mice with systemic lupus erythematosus and small coronary artery disease.

Authors:  H Yoshida; H Fujiwara; T Fujiwara; S Ikehara; Y Hamashima
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

10.  Immunoelectron microscopic study of plasma protein pathways through the abnormal intestinal vasculature of HgCl2 induced immune disease in brown Norway rats.

Authors:  N Hinglais; J Grossetete; M Paing; P Druet; J Bariety
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.